An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD)
Clinical trial NCT06254482 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06254482
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2029-07-16
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.